BI-505: Ph II discontinued

BioInvent discontinued an open-label, U.S. Phase II trial evaluating IV

Read the full 106 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE